AU2015365885B2 - A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions - Google Patents
A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions Download PDFInfo
- Publication number
- AU2015365885B2 AU2015365885B2 AU2015365885A AU2015365885A AU2015365885B2 AU 2015365885 B2 AU2015365885 B2 AU 2015365885B2 AU 2015365885 A AU2015365885 A AU 2015365885A AU 2015365885 A AU2015365885 A AU 2015365885A AU 2015365885 B2 AU2015365885 B2 AU 2015365885B2
- Authority
- AU
- Australia
- Prior art keywords
- casein
- acetyl
- iron
- aspartylated
- chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4732—Casein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14386034.4A EP3034512B1 (en) | 2014-12-19 | 2014-12-19 | A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions |
| EP14386034.4 | 2014-12-19 | ||
| PCT/EP2015/074482 WO2016096203A1 (en) | 2014-12-19 | 2015-10-22 | A process for producing iron (iii) casein n-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2015365885A1 AU2015365885A1 (en) | 2017-03-16 |
| AU2015365885B2 true AU2015365885B2 (en) | 2018-11-15 |
Family
ID=52354737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2015365885A Active AU2015365885B2 (en) | 2014-12-19 | 2015-10-22 | A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US20170340747A1 (forum.php) |
| EP (1) | EP3034512B1 (forum.php) |
| AP (1) | AP2017009801A0 (forum.php) |
| AU (1) | AU2015365885B2 (forum.php) |
| BR (1) | BR112017006621B1 (forum.php) |
| CA (1) | CA2959226C (forum.php) |
| CL (1) | CL2017001611A1 (forum.php) |
| CO (1) | CO2017003313A2 (forum.php) |
| CY (1) | CY1120037T1 (forum.php) |
| DK (1) | DK3034512T3 (forum.php) |
| EA (1) | EA031968B1 (forum.php) |
| ES (1) | ES2655238T3 (forum.php) |
| GE (1) | GEP20207081B (forum.php) |
| HR (1) | HRP20171965T1 (forum.php) |
| HU (1) | HUE035302T2 (forum.php) |
| IL (1) | IL251449B (forum.php) |
| LT (1) | LT3034512T (forum.php) |
| MX (1) | MX374777B (forum.php) |
| MY (1) | MY185391A (forum.php) |
| NO (1) | NO3034512T3 (forum.php) |
| PE (1) | PE20180660A1 (forum.php) |
| PH (1) | PH12017500391B1 (forum.php) |
| PL (1) | PL3034512T3 (forum.php) |
| PT (1) | PT3034512T (forum.php) |
| RS (1) | RS56714B1 (forum.php) |
| SA (1) | SA517381261B1 (forum.php) |
| SG (1) | SG11201702593TA (forum.php) |
| SI (1) | SI3034512T1 (forum.php) |
| SM (1) | SMT201800008T1 (forum.php) |
| WO (1) | WO2016096203A1 (forum.php) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1009589B (el) * | 2018-04-05 | 2019-09-11 | Ιουλια Κλεωνος Τσετη | Φαρμακευτικο σκευασμα για την αντιμετωπιση της αναιμιας, σε καταλληλο περιεκτη, που διατηρει στεγανα διαχωρισμενα μεταξυ τους τα δραστικα συστατικα: συμπλοκο του τρισθενους σιδηρου με ν-ακετυλο-l-ασπαρτικη καζεϊνη και πενταϋδρικο φυλλινικο ασβεστιο |
| CN116655512A (zh) * | 2023-05-31 | 2023-08-29 | 江苏阿尔法药业股份有限公司 | 一种卡托普利的制备工艺 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006021843A1 (en) * | 2004-07-29 | 2006-03-02 | Biofer S.P.A. | A process for producing iron succinyl casein and acetyl-aspartate iron casein complexes and use thereof in pharmaceutical mixtures |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB910321A (en) | 1960-02-25 | 1962-11-14 | Olivier Paul Gaudin | Improvements in and relating to a process for preparing ferrous salts of aspartic acid and medicines containing these salts |
| IT1150213B (it) | 1982-03-02 | 1986-12-10 | Italfarmaco Spa | Derivati di ferro biodisponibile esenti da gastrolesivita',procentimento di preparazione e relative composizioni farmaceutiche |
| IT1207996B (it) | 1986-03-18 | 1989-06-01 | Magis Farmaceutici | Composti contenenti ferro biodisponibile, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
| GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
| IT1297022B1 (it) | 1997-12-24 | 1999-08-03 | Chemi Spa | Complesso di ferro-succinilcaseina, processo per la sua preparazione e composizioni farmaceutiche che lo contengono |
-
2014
- 2014-12-19 ES ES14386034.4T patent/ES2655238T3/es active Active
- 2014-12-19 HU HUE14386034A patent/HUE035302T2/en unknown
- 2014-12-19 PL PL14386034T patent/PL3034512T3/pl unknown
- 2014-12-19 EP EP14386034.4A patent/EP3034512B1/en active Active
- 2014-12-19 RS RS20171312A patent/RS56714B1/sr unknown
- 2014-12-19 SI SI201430535T patent/SI3034512T1/en unknown
- 2014-12-19 SM SM20180008T patent/SMT201800008T1/it unknown
- 2014-12-19 LT LTEP14386034.4T patent/LT3034512T/lt unknown
- 2014-12-19 DK DK14386034.4T patent/DK3034512T3/en active
- 2014-12-19 PT PT143860344T patent/PT3034512T/pt unknown
- 2014-12-19 NO NO14386034A patent/NO3034512T3/no unknown
-
2015
- 2015-10-22 GE GEAP201514514A patent/GEP20207081B/en unknown
- 2015-10-22 MX MX2017008100A patent/MX374777B/es active IP Right Grant
- 2015-10-22 US US15/536,855 patent/US20170340747A1/en not_active Abandoned
- 2015-10-22 CA CA2959226A patent/CA2959226C/en active Active
- 2015-10-22 EA EA201790902A patent/EA031968B1/ru unknown
- 2015-10-22 MY MYPI2017701462A patent/MY185391A/en unknown
- 2015-10-22 WO PCT/EP2015/074482 patent/WO2016096203A1/en active Application Filing
- 2015-10-22 PE PE2017000363A patent/PE20180660A1/es unknown
- 2015-10-22 SG SG11201702593TA patent/SG11201702593TA/en unknown
- 2015-10-22 AP AP2017009801A patent/AP2017009801A0/en unknown
- 2015-10-22 AU AU2015365885A patent/AU2015365885B2/en active Active
- 2015-10-22 BR BR112017006621-1A patent/BR112017006621B1/pt active IP Right Grant
-
2017
- 2017-03-02 PH PH12017500391A patent/PH12017500391B1/en unknown
- 2017-03-29 IL IL251449A patent/IL251449B/en active IP Right Grant
- 2017-04-05 CO CONC2017/0003313A patent/CO2017003313A2/es unknown
- 2017-04-05 SA SA517381261A patent/SA517381261B1/ar unknown
- 2017-06-19 CL CL2017001611A patent/CL2017001611A1/es unknown
- 2017-12-19 HR HRP20171965TT patent/HRP20171965T1/hr unknown
- 2017-12-21 CY CY20171101341T patent/CY1120037T1/el unknown
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006021843A1 (en) * | 2004-07-29 | 2006-03-02 | Biofer S.P.A. | A process for producing iron succinyl casein and acetyl-aspartate iron casein complexes and use thereof in pharmaceutical mixtures |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2006324080B2 (en) | Process for the preparation of ferri-succinylcasein | |
| JPH0458946B2 (forum.php) | ||
| IE54572B1 (en) | Pharmaceutically active succinylated proteins comprising iron | |
| AU2015365885B2 (en) | A process for producing iron (III) casein N-acetyl-aspartylated complexes and use thereof in pharmaceutical compositions | |
| KR100563361B1 (ko) | 페로-숙신일카제인 착화물, 그 제조방법 및 이를 함유하는 약제조성무류 | |
| OA18236A (en) | A process for producing iron (III) casein Nacetyl-aspartylated complexes and use thereof in pharmaceutical compositions. | |
| JPS62209100A (ja) | 生体に有用な性質を持つグロビン及びアセチルグロビンの鉄誘導体、その調製法及び薬学的処方物 | |
| KR970008109B1 (ko) | 생물학적으로 매우 유용한 형태의 철을 함유한 단백질 유도체, 그의 제조방법 및 이 화합물을 함유하는 제약 조성물 | |
| JPH08103246A (ja) | ウニ由来カルシウムの製造方法ならびにこの製造方法に よって得られる易吸収性カルシウムを含有する組成物 | |
| JPH0947253A (ja) | 易吸収性カルシウムを含有する組成物およびその製造 方法 | |
| KR100513011B1 (ko) | 가용성 칼슘-핵산물질 복합체 및 그 제조방법 | |
| HK1125115A (en) | Process for the preparation of ferri-succinylcasein | |
| WO1993008830A1 (en) | Compounds of bioavailable iron with acylated ovotransferrin or with acylated hydrolysis derivatives thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |